A recent study indicates that VDR polymorphisms may interact with circulating levels of vitamin D (25(OH)D) in determining major clinical outcomes, including a composite outcome of incident hip fracture, myocardial infarction (MI), cancer, and mortality [6]. This evidence concerns the gene VDR and cancer.